Companies / Santa Cruz Biotechnology / ACOT8 (C-3) FITC
Santa Cruz Biotechnology

ACOT8 (C-3) FITC | Santa Cruz Biotechnology

mouse monoclonal IgG1; ACOT8 Antibody (C-3) is an IgG1 κ mouse monoclonal ACOT8 antibody (also designated ACOT8 antibody) that detects the ACOT8 protein of mouse, rat and human origin by WB, IP, IF and ELISA. ACOT8 Antibody (C-3) is available as both the non-conjugated anti-ACOT8 antibody form, as well as multiple conjugated forms of anti-ACOT8 antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. ACOT8 (Acyl-CoA thioesterase 8), also designated TEII p35 or hTE, is a novel human thioesterase known to interact with the HIV protein Nef using yeast two-hybrid screening. Nef is an auxiliary gene of the human immunodeficiency virus (HIV) which facilitates virus replication and enhances infectivity. The roles of Nef in HIV-infected cells are likely mediated by specific interactions with cellular proteins. The interaction between Nef and ACOT8 is correlated with CD4 downregulation, suggesting that ACOT8 may be involved in Nef-mediated CD4 downregulation in HIV-infected cells. ACOT8 is 42% identical to thioesterase II from Escherichia coli, and has no significant homology with the two types of animal thioesterases that have previously been cloned (type I and type II thioesterases).

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.